Antiretroviral therapies in HIV-1 infection

Expert Opinion on Investigational Drugs

Volumn 6, Issue 8, 1997, Pages 1049-1061

  Morris Jones, S ^a   Moyle, G ^a   Easterbrook, P J ^a  

^a CHELSEA AND WESTMINSTER HOSPITAL   (United Kingdom)

Author keywords

Antiretroviral therapy; Drug trials; Human immunodeficiency virus

Indexed keywords

ABACAVIR; AMPRENAVIR; ANTIRETROVIRUS AGENT; CD4 ANTIGEN; DELAVIRDINE; DIDANOSINE; EFAVIRENZ; INDINAVIR; LAMIVUDINE; LOVIRIDE; NELFINAVIR; NEVIRAPINE; PROTEINASE INHIBITOR; RITONAVIR; RNA DIRECTED DNA POLYMERASE INHIBITOR; SAQUINAVIR; STAVUDINE; UNCLASSIFIED DRUG; ZALCITABINE; ZIDOVUDINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; CLINICAL PROTOCOL; CLINICAL TRIAL; EUROPE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LICENCE; UNITED STATES;

EID: 0030765142     PISSN: 13543784     EISSN: None     Source Type: Journal    
DOI: 10.1517/13543784.6.8.1049     Document Type: Article

References (54)